Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

about

9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.

P2860

Q33674869-F7AEB32B-421E-4082-8781-E9094357A0D0 Q42433305-1FE2F8EA-3C8E-4C1F-98A7-F0EEE38F6717

P2860

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q36153387

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@ast

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@en

type

Item

label

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@ast

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@en

prefLabel

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@ast

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@en

P1476

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

@en

P2093

Ee Tuan Lim

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

Multiple sclerosis

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

P304

379-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.5.3.379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gavin Giovannoni

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15938671

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

multiple sclerosis

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

about

P2860

P2860

Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921